MeCP2 Repression of G9a in Regulation of Pain and Morphine Reward

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Neuroscience

• Publication date

  2014-07-02

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1523/JNEUROSCI.4194-13.2014PMID 24990928PMCID PMC4078085
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• G9a, a multipotent regulator of gene expression

  2013cited by this paper
• Central Amygdala GluA1 Facilitates Associative Learning of Opioid Reward

  2013influential reference
• Changes in morphine reward in a model of neuropathic pain

  2013cited by this paper
• Modulation of central nervous system–specific microRNA‐124a alters the inflammatory response in the formalin test in mice

  2013cited by this paper
• Activity-dependent phosphorylation of MeCP2 threonine 308 regulates interaction with NCoR

  2013cited by this paper
• Morphine Epigenomically Regulates Behavior through Alterations in Histone H3 Lysine 9 Dimethylation in the Nucleus Accumbens

  2012influential reference
• The expression of spinal methyl-CpG-binding protein 2, DNA methyltransferases and histone deacetylases is modulated in persistent pain states

  2012cited by this paper
• Chronic Pain: Emerging Evidence for the Involvement of Epigenetics

  2012cited by this paper
• Neurobiology of the incubation of drug craving.

  2011cited by this paper
• The role of MeCP2 in the brain.

  2011cited by this paper
• Epigenetic suppression of GAD65 expression mediates persistent pain

  2011cited by this paper
• Complexities of Rett Syndrome and MeCP2

  2011cited by this paper
• Transcriptional and epigenetic mechanisms of addiction

  2011cited by this paper
• Addictions in pain clinics and pain treatment

  2011cited by this paper
• Behavioral indices of ongoing pain are largely unchanged in male mice with tissue or nerve injury‐induced mechanical hypersensitivity

  2011cited by this paper
• MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212

  2010influential reference
• Cocaine-Induced Chromatin Remodeling Increases Brain-Derived Neurotrophic Factor Transcription in the Rat Medial Prefrontal Cortex, Which Alters the Reinforcing Efficacy of Cocaine

  2010cited by this paper
• Essential Role of the Histone Methyltransferase G9a in Cocaine-Induced Plasticity

  2010cited by this paper
• MeCP2 in the Nucleus Accumbens Contributes to Neural and Behavioral Responses to Psychostimulants

  2010influential reference
• Unmasking the tonic-aversive state in neuropathic pain

  2009cited by this paper
• Forebrain pain mechanisms.

  2009influential reference
• Ethanol-induced delta-opioid receptor modulation of glutamate synaptic transmission and conditioned place preference in central amygdala.

  2009cited by this paper
• Cellular and molecular mechanisms of pain.

  2009cited by this paper
• MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription

  2008influential reference
• Chronic pain alters drug self-administration: implications for addiction and pain mechanisms.

  2008cited by this paper
• Protein lysine methyltransferase G9a acts on non-histone targets.

  2008cited by this paper
• Chromatin crosstalk in development and disease: lessons from REST

  2007cited by this paper
• The role of chromatin during transcription.

  2007cited by this paper
• Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non‐cancer pain

  2007cited by this paper
• A Role for Transcriptional Repressor Methyl-CpG-Binding Protein 2 and Plasticity-Related Gene Serum- and Glucocorticoid-Inducible Kinase 1 in the Induction of Inflammatory Pain States

  2007cited by this paper
• Opioid dependence and addiction during opioid treatment of chronic pain

  2007cited by this paper
• Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes

  2007cited by this paper
• REVIEW ON CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade

  2007cited by this paper
• The ups and downs of BDNF in Rett syndrome.

  2006cited by this paper
• Neural mechanisms of addiction: the role of reward-related learning and memory.

  2006cited by this paper
• Neurotrophins: mediators and modulators of pain.

  2006cited by this paper
• Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized

  2006cited by this paper
• The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression.

  2006cited by this paper
• Direct Evidence for the Involvement of the Mesolimbic κ-Opioid System in the Morphine-Induced Rewarding Effect Under an Inflammatory Pain-Like State

  2005cited by this paper
• Restoration of spatial working memory by genetic rescue of GluR-A–deficient mice

  2005cited by this paper
• State-dependent opioid control of pain

  2004influential reference
• Use and abuse of opioid analgesics: potential methods to prevent and deter non-medical consumption of prescription opioids.

  2004cited by this paper
• Neurobiological mechanisms in the transition from drug use to drug dependence.

  2004cited by this paper
• Encoding Predictive Reward Value in Human Amygdala and Orbitofrontal Cortex

  2003cited by this paper
• Derepression of BDNF Transcription Involves Calcium-Dependent Phosphorylation of MeCP2

  2003cited by this paper
• DNA Methylation-Related Chromatin Remodeling in Activity-Dependent Bdnf Gene Regulation

  2003cited by this paper
• Suppression of the morphine-induced rewarding effect and G-protein activation in the lower midbrain following nerve injury in the mouse: involvement of G-protein-coupled receptor kinase 2.

  2003cited by this paper
• Drug Addiction, Relapse, and the Amygdala

  2003cited by this paper
• The amygdala and reward

  2002cited by this paper
• Reward circuitry activation by noxious thermal stimuli.

  2001cited by this paper
• Regional Mu Opioid Receptor Regulation of Sensory and Affective Dimensions of Pain

  2001cited by this paper
• Opiate self‐administration as a measure of chronic nociceptive pain in arthritic rats

  2001cited by this paper
• Cellular mechanism for anti-analgesic action of agonists of the κ-opioid receptor

  1997cited by this paper
• Cellular mechanism for anti-analgesic action of agonists of the kappa-opioid receptor.

  1997cited by this paper
• Organization of intra-amygdaloid circuitries in the rat: an emerging framework for understanding functions of the amygdala.

  1997cited by this paper
• The consumption of fentanyl is increased in rats with nociceptive but not with neuropathic pain

  1995cited by this paper
• Conditioned place preference paradigm: a novel approach for analgesic drug assessment against chronic pain

  1994cited by this paper
• Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA.

  1992cited by this paper

• Epigenetic mechanisms and therapeutic innovations in chronic pain‐associated neuropsychiatric co‐morbidities

  2026cites this paper
• Ghrelin restores D1 receptor-mediated dopamine neurotransmission and enhances attentive behaviour in Mecp2 KO mice.

  2025cites this paper
• Sex-specific role of the 5-HT2A receptor in psilocybin-induced extinction of opioid reward

  2025cites this paper
• Targeting G9a decreases escalated alcohol drinking in male mice in a model of combined stress and chronic alcohol exposure

  2025cites this paper
• BDNF Signaling and Pain Modulation

  2025influential citation
• Epigenetic Insights into Substance Use Disorder and Associated Psychiatric Conditions

  2025cites this paper
• Alcohol Consumption Modulates the Development of Chronic Pain in COVID-19 Patients: A Network Meta-Analysis

  2025cites this paper
• Upregulation of the neuropeptide receptor calcitonin receptor-like in the spinal cord via MLL2 in a mouse model of paclitaxel-induced peripheral neuropathy

  2025cites this paper
• Epigenetic modifications associated to diabetic peripheral neuropathic pain (Review)

  2024cites this paper
• Elucidating the molecular symphony: unweaving the transcriptional & epigenetic pathways underlying neuroplasticity in opioid dependence and withdrawal

  2024cites this paper
• The single-cell opioid responses in the context of HIV (SCORCH) consortium

  2024cites this paper
• A master regulator of opioid reward in the ventral prefrontal cortex

  2024cites this paper
• Role of primary aging hallmarks in Alzheimer´s disease

  2023cites this paper
• The role of the gut microbiome and microbial metabolism in mediating opioid-induced changes in the epigenome

  2023cites this paper
• Histone modifications in cocaine, methamphetamine and opioids

  2023cites this paper
• Spinal Astrocytic MeCP2 Regulates Kir4.1 for the Maintenance of Chronic Hyperalgesia in Neuropathic Pain.

  2023cites this paper
• Global research trends on epigenetics and neuropathic pain: A bibliometric analysis

  2023cites this paper
• Comprehensive Volumetric Analysis of Mecp2-Null Mouse Model for Rett Syndrome by T2-Weighted 3D Magnetic Resonance Imaging

  2022cites this paper
• Epigenetic Modulation of Opioid Receptors by Drugs of Abuse

  2022cites this paper
• Normalization of the H3K9me2/H3K14ac-ΔFosB pathway in the nucleus accumbens underlying the reversal of morphine-induced behavioural and synaptic plasticity by Compound 511.

  2022cites this paper
• MiR-199-3p Suppressed Inflammatory Response by Targeting MECP2 to Alleviate TRX-Induced PHN in Mice

  2022cites this paper
• Epigenetic Alterations in Prescription Opioid Misuse: New Strategies for Precision Pain Management

  2021cites this paper
• Epigenetic Regulations of Microglia/Macrophage Polarization in Ischemic Stroke

  2021cites this paper
• MeCP2 mediates transgenerational transmission of chronic pain

  2020cites this paper
• Epigenetic Mechanisms of Opioid Addiction.

  2020influential citation
• GluA1 in central amygdala increases pain but inhibits opioid withdrawal-induced aversion

  2020cites this paper
• Research Status and Application Prospect of Epigenetic Regulation of BDNF Gene Expression in Chronic Pain

  2019cites this paper
• Persistent Nociception Facilitates the Extinction of Morphine-Induced Conditioned Place Preference.

  2019cites this paper
• Morphine Exacerbates Postfracture Nociceptive Sensitization, Functional Impairment, and Microglial Activation in Mice

  2019cites this paper
• Epigenetics and memory: Emerging role of histone lysine methyltransferase G9a/GLP complex as bidirectional regulator of synaptic plasticity.

  2019cites this paper
• Core Outcome Measures in Preclinical Assessment of Candidate Analgesics

  2019cites this paper
• Emphasizing Histone-Related Chromatin Remodeling in the Central Nervous System of Animal Models of Chronic Pain

  2019cites this paper
• Pain-Induced Chromatin Modifications

  2019cites this paper
• Incisional Injury Modulates Morphine Reward and Morphine-Primed Reinstatement: A Role of Kappa Opioid Receptor Activation.

  2019cites this paper
• Threshold Inhibition of Methyltransferase G9a/Glp Exacerbates Neuropathic Hypersensitivity through Mediating GRIN2B Methylation

  2019cites this paper
• GluA1 in central amygdala promotes opioid use and reverses inhibitory effect of pain.

  2019cites this paper
• Knockdown of the histone di-methyltransferase G9a in nucleus accumbens shell decreases cocaine self-administration, stress-induced reinstatement, and anxiety

  2018cites this paper
• Epigenetics: the panacea for cognitive decline?

  2018cites this paper
• A medial prefrontal cortex-nucleus acumens corticotropin-releasing factor circuitry for neuropathic pain-increased susceptibility to opioid reward

  2018cites this paper
• Brain Circuits Mediating Opposing Effects on Emotion and Pain

  2018cites this paper
• G9a/GLP Complex Acts as a Bidirectional Switch to Regulate Metabotropic Glutamate Receptor-Dependent Plasticity in Hippocampal CA1 Pyramidal Neurons.

  2018cites this paper
• REST overexpression in mice causes deficits in spontaneous locomotion

  2018cites this paper
• Effects of Single Injections of Brain-Derived Neurotrophic Factors into the Midline Ventral Tegmental Area on the Reinforcing Properties of Morphine

  2017influential citation
• Endogenous Opiates and Behavior: 2015.

  2017cites this paper
• Overexpression of the Histone Dimethyltransferase G9a in Nucleus Accumbens Shell Increases Cocaine Self-Administration, Stress-Induced Reinstatement, and Anxiety

  2017influential citation
• A novel mutation R190H in the AT-hook 1 domain of MeCP2 identified in an atypical Rett syndrome

  2017cites this paper
• Epigenetic regulation by G9a/GLP complex ameliorates amyloid‐beta 1‐42 induced deficits in long‐term plasticity and synaptic tagging/capture in hippocampal pyramidal neurons

  2017cites this paper
• Epigenetics in Chronic Pain

  2017cites this paper
• Pain in Rett syndrome: peculiarities in pain processing and expression, liability to pain causing disorders and diseases, and specific aspects of pain assessment

  2017cites this paper
• Threshold effect of G9a/Glp on peripheral nerve injury-induced hypersensitivity

  2017cites this paper
• Brain-derived neurotrophic factor involved epigenetic repression of UGT2B7 in colorectal carcinoma: A mechanism to alter morphine glucuronidation in tumor

  2017cites this paper
• Histone Methylation by the Kleefstra Syndrome Protein EHMT1 Mediates Homeostatic Synaptic Scaling.

  2016cites this paper
• Interactions between Early Life Stress, Nucleus Accumbens MeCP2 Expression, and Methamphetamine Self-Administration in Male Rats

  2016influential citation
• Dopaminergic inhibition by G9a/Glp complex on tyrosine hydroxylase in nerve injury-induced hypersensitivity

  2016cites this paper
• Genome-wide redistribution of MeCP2 in dorsal root ganglia after peripheral nerve injury

  2016cites this paper
• G9a participates in nerve injury-induced Kcna2 downregulation in primary sensory neurons

  2016cites this paper
• Targeting Epigenetic Mechanisms for Chronic Pain: A Valid Approach for the Development of Novel Therapeutics

  2016cites this paper
• MicroRNA may regulate the content of the brain-derived neurotrophic factor in the frontal cortex of rats after spontaneous morphine withdrawal

  2016cites this paper
• Pharmacological Inhibition of the G9a/GLP Histone Methyltransferase and Anxiety-related Behaviour in the Mouse

  2016cites this paper
• Epigenetics of Pain Management

  2016cites this paper
• Inhibition of G9a/GLP Complex Promotes Long-Term Potentiation and Synaptic Tagging/Capture in Hippocampal CA1 Pyramidal Neurons

  2016cites this paper
• Regulation of cell differentiation and function by the euchromatin histone methyltranserfases G9a and GLP.

  2016cites this paper
• Epigenetics and Personalized Pain Management

  2015cites this paper
• Could targeting epigenetic processes relieve chronic pain states?

  2015cites this paper
• Persistent Pain Maintains Morphine-Seeking Behavior after Morphine Withdrawal through Reduced MeCP2 Repression of Glua1 in Rat Central Amygdala

  2015cites this paper
• Epigenetic regulation of chronic pain.

  2015cites this paper
• MeCP2 plays an analgesic role in pain transmission through regulating CREB / miR-132 pathway

  2015cites this paper
• MicroRNAs downregulated in neuropathic pain regulate MeCP2 and BDNF related to pain sensitivity

  2015cites this paper
• Epigenetic modulation of Wnt signaling contributes to neuropathic pain in rats.

  2015cites this paper
• The neurobiology of pain perception in normal and persistent pain.

  2015cites this paper